Early Biomarkers in the Prediction of Later Functional Impairment in Term Children with Cerebral Palsy

Pediatr Neurol. 2023 Mar:140:59-64. doi: 10.1016/j.pediatrneurol.2022.12.004. Epub 2022 Dec 24.

Abstract

Aim: To identify possible early biomarkers that could predict later functional capabilities in children at risk for cerebral palsy (CP).

Methods: Data from 869 term children with CP were extracted from the Canadian Cerebral Palsy Registry. Univariate analyses were conducted to measure the association between readily available objective early biomarkers (neonatal encephalopathy [NE], cord or first hour of life pH, magnetic resonance imaging [MRI]) and functional outcomes such as mobility and feeding status. Multivariable regressions were then modeled to study whether adding predictors would affect the strength of the observed association.

Results: Patients with NE have higher odds of having an assigned Gross Motor Function Classification Score level of IV to V (prevalence ratio [PR], 2.87; 95% confidence interval [CI], 2.07 to 3.97) and are more likely to require dependent tube feeding (PR, 2.09; 95% CI, 1.12 to 3.88); this was similarly seen in patients with MRI findings of deep gray matter injury, watershed injury, near-total brain injury, and/or cortical malformation (mobility status [PR, 5.13; 95% CI, 3.73 to 7.11] and feeding status [PR, 4.87; 95% CI, 2.57 to 9.75]). Patients with cord or first hour of life pH <7 were also more likely to predict dependent mobility status (PR, 2.86; 95% CI, 1.76 to 4.69), however, not significantly more likely to predict eventual dependent feeding status (PR, 1.47; 95% CI, 0.58 to 3.32).

Conclusions: This retrospective cohort study demonstrates that NE, MRI findings and cord or first hour of life pH can reliably predict later CP related functioning. These associations can be used to inform and clarify early prognosis discussions between caregivers and health professionals.

Keywords: Biomarkers; Cerebral palsy; Functional impairment; Neonatal; Prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Brain Injuries*
  • Canada
  • Cerebral Palsy*
  • Child
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Retrospective Studies

Substances

  • Biomarkers